NUWE vs PACB

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 15, 2026

NUWE

39.8
AI Score
VS
PACB Wins

PACB

41.9
AI Score

Investment Advisor Scores

NUWE

40score
Recommendation
AVOID NEW MONEY

PACB

42score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NUWE PACB Winner
Forward P/E 0 0 Tie
PEG Ratio 0 -0.17 Tie
Revenue Growth 14.1% -1.9% NUWE
Earnings Growth -99.2% 0.0% PACB
Tradestie Score 39.8/100 41.9/100 PACB
Profit Margin -125.6% -82.5% PACB
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD PACB

Relative Price Performance (Last 90 Days)

NUWE 1M: -37.3% · 3M: -82.0% PACB 1M: +48.5% · 3M: +33.6%

Current Technical Phase

NUWE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -44.1%), weak momentum, RSI 29

RSI (14): 29.3 · Price: $0.53

PACB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (16.7% over 20 days), RSI 51

RSI (14): 51.1 · Price: $1.99

Fundamentals Snapshot

Metric NUWE PACB
Market Cap — —
Forward P/E -0.8 -4.7
Trailing P/E 0.0 —
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.7% 0.3%
Operating Margin -1.6% -1.1%
EPS 435.92 -0.43
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, PACB is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.